177 related articles for article (PubMed ID: 24974927)
1. [Peptidylarginine deiminase type4 (PADI4) role in immune system].
Seri Y; Shoda H; Matsumoto I; Sumida T; Fujio K; Yamamoto K
Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(3):154-9. PubMed ID: 24974927
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features.
Reyes-Castillo Z; Palafox-Sánchez CA; Parra-Rojas I; Martínez-Bonilla GE; del Toro-Arreola S; Ramírez-Dueñas MG; Ocampo-Bermudes G; Muñoz-Valle JF
Clin Exp Immunol; 2015 Nov; 182(2):119-31. PubMed ID: 26149185
[TBL] [Abstract][Full Text] [Related]
3. Localization of peptidylarginine deiminase 4 (PADI4) and citrullinated protein in synovial tissue of rheumatoid arthritis.
Chang X; Yamada R; Suzuki A; Sawada T; Yoshino S; Tokuhiro S; Yamamoto K
Rheumatology (Oxford); 2005 Jan; 44(1):40-50. PubMed ID: 15466895
[TBL] [Abstract][Full Text] [Related]
4. The lack of association between PADI4_94 or PADI4_104 polymorphisms and RF, ACPA and anti-PAD4 in patients with rheumatoid arthritis.
Ciesla M; Kolarz B; Darmochwal-Kolarz D
Sci Rep; 2022 Jul; 12(1):11882. PubMed ID: 35831381
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of functional haplotypes of the peptidylarginine deiminase citrullinating enzyme gene in patients with rheumatoid arthritis: no influence of the presence of anti-citrullinated peptide antibodies.
Faragó B; Talián GC; Maász A; Magyari L; Horvatovich K; Kovács B; Cserép V; Kisfali P; Kiss CG; Czirják L; Melegh B
Clin Exp Rheumatol; 2007; 25(4):523-8. PubMed ID: 17888206
[TBL] [Abstract][Full Text] [Related]
6. Peptidylarginine deiminase 4 (PADI4) identified as a conformation-dependent autoantigen in rheumatoid arthritis.
Takizawa Y; Sawada T; Suzuki A; Yamada R; Inoue T; Yamamoto K
Scand J Rheumatol; 2005; 34(3):212-5. PubMed ID: 16134727
[TBL] [Abstract][Full Text] [Related]
7. Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.
Suzuki A; Kochi Y; Shoda H; Seri Y; Fujio K; Sawada T; Yamada R; Yamamoto K
BMC Musculoskelet Disord; 2016 May; 17():205. PubMed ID: 27150598
[TBL] [Abstract][Full Text] [Related]
8. Citrullinated proteins in rheumatoid arthritis.
Yamada R; Suzuki A; Chang X; Yamamoto K
Front Biosci; 2005 Jan; 10():54-64. PubMed ID: 15574347
[TBL] [Abstract][Full Text] [Related]
9. PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation.
Zavala-Cerna MG; Gonzalez-Montoya NG; Nava A; Gamez-Nava JI; Moran-Moguel MC; Rosales-Gomez RC; Gutierrez-Rubio SA; Sanchez-Corona J; Gonzalez-Lopez L; Davalos-Rodriguez IP; Salazar-Paramo M
Clin Dev Immunol; 2013; 2013():383681. PubMed ID: 24454473
[TBL] [Abstract][Full Text] [Related]
10. Peptidylarginine deiminase 4 and citrullination in health and disease.
Anzilotti C; Pratesi F; Tommasi C; Migliorini P
Autoimmun Rev; 2010 Jan; 9(3):158-60. PubMed ID: 19540364
[TBL] [Abstract][Full Text] [Related]
11. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis.
Too CL; Murad S; Dhaliwal JS; Larsson P; Jiang X; Ding B; Alfredsson L; Klareskog L; Padyukov L
Arthritis Res Ther; 2012 Nov; 14(6):R250. PubMed ID: 23164236
[TBL] [Abstract][Full Text] [Related]
13. Polymorphisms and functional haplotype in PADI4: further evidence for contribution on rheumatoid arthritis susceptibility and anti-cyclic citrullinated peptide antibodies in a western Mexican population.
Guzmán-Guzmán IP; Reyes-Castillo Z; Muñoz-Barrios S; Ruiz-Noa Y; Martínez-Bonilla GE; Parra-Rojas I; Palafox-Sánchez CA; Muñoz-Valle JF
Immunol Lett; 2015 Feb; 163(2):214-20. PubMed ID: 25562673
[TBL] [Abstract][Full Text] [Related]
14. Peptidylarginine deiminase type 4 deficiency reduced arthritis severity in a glucose-6-phosphate isomerase-induced arthritis model.
Seri Y; Shoda H; Suzuki A; Matsumoto I; Sumida T; Fujio K; Yamamoto K
Sci Rep; 2015 Aug; 5():13041. PubMed ID: 26293116
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of antithrombin by peptidylarginine deiminase 4 may contribute to pathogenesis of rheumatoid arthritis.
Chang X; Yamada R; Sawada T; Suzuki A; Kochi Y; Yamamoto K
Rheumatology (Oxford); 2005 Mar; 44(3):293-8. PubMed ID: 15561738
[TBL] [Abstract][Full Text] [Related]
16. Periodontal sources of citrullinated antigens and TLR agonists related to RA.
Vitkov L; Hannig M; Minnich B; Herrmann M
Autoimmunity; 2018 Sep; 51(6):304-309. PubMed ID: 30417696
[TBL] [Abstract][Full Text] [Related]
17. Molecular Factors in PAD2 (
Nava-Quiroz KJ; Rojas-Serrano J; Pérez-Rubio G; Buendia-Roldan I; Mejía M; Fernández-López JC; Rodríguez-Henríquez P; Ayala-Alcantar N; Ramos-Martínez E; López-Flores LA; Del Ángel-Pablo AD; Falfán-Valencia R
Cells; 2023 Sep; 12(18):. PubMed ID: 37759458
[TBL] [Abstract][Full Text] [Related]
18. Release of Active Peptidyl Arginine Deiminases by Neutrophils Can Explain Production of Extracellular Citrullinated Autoantigens in Rheumatoid Arthritis Synovial Fluid.
Spengler J; Lugonja B; Ytterberg AJ; Zubarev RA; Creese AJ; Pearson MJ; Grant MM; Milward M; Lundberg K; Buckley CD; Filer A; Raza K; Cooper PR; Chapple IL; Scheel-Toellner D
Arthritis Rheumatol; 2015 Dec; 67(12):3135-45. PubMed ID: 26245941
[TBL] [Abstract][Full Text] [Related]
19. Association between PADI4 gene polymorphisms and anti-cyclic citrullinated peptide antibody positive rheumatoid arthritis in a large Chinese Han cohort.
Du Y; Liu X; Guo JP; Liu X; Li R; Zhao Y; Liu X; Li MH; Li ZG
Clin Exp Rheumatol; 2014; 32(3):377-82. PubMed ID: 24564960
[TBL] [Abstract][Full Text] [Related]
20. Clinical and immunological aspects of anti-peptidylarginine deiminase type 4 (anti-PAD4) autoantibodies in rheumatoid arthritis.
Reyes-Castillo Z; Muñoz-Valle JF; Llamas-Covarrubias MA
Autoimmun Rev; 2018 Feb; 17(2):94-102. PubMed ID: 29196243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
